Our study demonstrates the antagonism between DOT1 and H3K9me2 at enhancers of developing animals for the first time, to the best of our knowledge, although specific enhancers enriched in H3K79me have been described in leukemia cells [86,87]. The gene discussed is DOT1L; the disease is leukemia.